Accelerating Precision Medicine and Early Detection

ConquerX's EbeGen technology represents a game-changing approach on molecular profiling and analysis by leveraging a combination of a biosensor technology and high performance nanocomposite to detection of molecular targets fast and accurate.

Current challenges in molecular diagnostics

Single Target

Lack capacity to analyze multiple types of biomarker targets from a single sample simultaneously

Time consuming

Average wait time of 3 - 7h per analysis causing longer time to realize negative results longer duration of trials.


Price ranges from $0.85 to $4 per target. The need to analyse multiple targets and multiple patients leads to high cost of drug development.

Our solution: The EbeGen

is an optimized electrochemical biosensor capable of run analyses of molecular biomarkers such DNA sequences, ctDNA and microRNA panels with a single biological sample without the need for amplification or sequencing.

The benefits EbeGen brings

Multiple targets

Analyzes different types of targets (DNA sequences, DNA mutations, microRNAs) at the same time in the same sample.


Results are available in 30 mins while competing technologies take between 3 to 7 hours.


Costs approximately 1/8 of the cost of qPCR and 1/40 of the cost of sequencing per target analysis.


Amplification, sequencing and complicated techniques are not required.

EbeGen's workflow

The Metachip workflow has three simple steps: draw blood, place the blood on the Metachip, and put the Metachip on a portable sensor-reader to get results in 15 minutes.

Blood Sampling

EbeGen Analysis

Results in 30 minutes

How we met

We are a multidisciplinary team with four members from three different continents, bound together by our passion for entrepreneurship and firm belief of using innovative technology to benefit humanity. The team grew out of the MITx Global Entrepreneurship Bootcamp 2015 - an intensive seven-day entrepreneurship training and startup competition led by Bill Aulet and Elaine Chen of the Martin Trust Center for MIT Entrepreneurship. As a team, we won the People’s Choice Startup Award and placed second in the final pitch competition.

Our Team

Deborah Zanforlin, M.Sc.

Co-founder, CEO

Biomedical scientist, biochemistry professor of DeVry Brazil University

Expert in biosensors, medical diagnostic devices, and early cancer detection technology

Silver medalist at the International Genetically Engineered Machine iGEM Competition hosted by MIT

Jakub Chudik

Co-founder, Chief Technology Officer

Candidate of B.S. in Mechanical Engineering at MIT

MIT Roboteam; background in robotics and software engineering

Gold medalist at the International Young Physicists' Tournament

To Nhu Huynh, MPH

Co-founder, Chief Operating Officer

Cancer education specialist at the University of Texas MD Anderson Cancer Center

Public health researcher with extensive research and outreach experience in cancer screening practices and policies

Experienced in research project management and health program management

John Hamilton (Cantab)


Hamilton is an accomplished executive with over 25+ years experience managing early stage startups to large company IPOs.

Hamilton has vast sales and marketing expertise that has spanned several well known Boston based companies from Stratus Computer, EMC, FTP Software, Concord Communications, Phase Forward, XKoto and Viewfinity.

Hamilton's ability to prepare companies for acquisition and or IPO has yielded significant returns for shareholders across the board.

Jeffrey C. Grossman


Professor of Materials Science and Engineering at MIT

Grossman has published more than 80 scientific papers on the topics of solar photovoltaics, thermoelectrics, hydrogen storage, solar fuels, nanomechanical phenomena, and self-assembly.

Jorge Sánchez López


Serial entrepreneur in international, fast-growing and disruptive markets

Former CEO of Simarks Software (Spain), Build-Your Business Consulting Group (USA), Best-Coffee (Dubai UAE & KSA) & former Business Development Manager for Symantec (Gulf, Levant & KSA)

Expert in business continuity and business consultancy services for international business development


We are proud members of the 2017 Pulse@MassChallenge Healthcare Accelerator

The Pulse@MassChallenge Boston is the most startup-friendly digital health lab, connecting entrepreneurs to experts, institutions and resources with no equity taken.

Finalists MassChallenge Boston 2016

MITx Global Entrepreneurship Bootcamp - 2nd place

MIT Sloan Healthcare Innovations Prize - Semifinalists

Company Address:


residents at MassChallenge
21 Drydock Avenue, 610E
Boston MA 02210